1643P Impact of PTEN alterations on clinical outcomes in patients (pts) with de novo metastatic prostate cancer (mPC)
Year: 2024
Type: article
Source: Annals of Oncology
Authors: B. Thapa, N. Henderson, S.T. Tagawa, C. Hwang, A.O. Sokolova, M.A. Bilen, P.M. Coelho Barata, C.B. Nguyen, A. Tripathi, A. Ayanambakkam, L.S. Graham, Y. Zakharia, V.S. Koshkin, E. Heath, T.B. Dorff, A.J. Armstrong, R.R. McKay, A.S. Alva, M. Schweizer, D. Kilari
Institutions: Froedtert Hospital, Medical College of Wisconsin, University of Michigan, Michigan Medicine, U-M Rogel Cancer Center, Weill Cornell Medicine, Weill Cornell Medical Center, Henry Ford Health, Henry Ford Hospital, Oregon Health & Science University, Winship Cancer Institute, University Hospitals Seidman Cancer Center, City Of Hope National Medical Center, City of Hope, OU Health Stephenson Cancer Center, University of Oklahoma Health Sciences Center, University of Colorado Cancer Center, University of Colorado Anschutz, University of Iowa Hospitals and Clinics, University of California, San Francisco, University of California San Francisco Medical Center, The Barbara Ann Karmanos Cancer Institute, Duke University, Duke Cancer Institute, University of California San Diego, University of Washington
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4402704935